Non-pregnant and non-lactating
Pregnant or lactating patients
Female patients who are pregnant and/or lactating are not eligible
Patients who are pregnant or lactating will not be eligible; pregnant patients are ineligible
Participants who are pregnant or lactating
Pregnant or lactating women
Is pregnant or lactating
Pregnant, lactating, or planning to become pregnant during the study and up to 3 months after last dose of study drug
Pregnant or lactating women
Women who are pregnant or lactating.
Pregnant or lactating
Women who are pregnant or lactating
Women who are pregnant or lactating
Not pregnant or lactating, willing to prevent pregnancy while on study and for 6 months after the last dose of XMT-1522
Pregnant or lactating females
Currently pregnant or lactating
Subject is pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females
Pregnant or lactating women
Women who are pregnant or lactating (breastfeeding)
Female subjects who are both lactating and breastfeeding
Female subjects who are pregnant or lactating.
Pregnant or lactating females.
Women who are pregnant or lactating
Lactating or pregnant woman
Pregnant or lactating females
Pregnant or lactating female
Pregnant or lactating females
Pregnant or lactating women
Pregnant or lactating women
Patient is pregnant or lactating.
Pregnant or lactating females are excluded
Pregnant or lactating females
Pregnant or lactating females
Pregnant or lactating women
Pregnant or lactating
Pregnant or lactating females
Pregnant or lactating women.
Must not be breastfeeding/lactating.
Subject who is pregnant or lactating.
Women who are pregnant or lactating
Pregnant or lactating women
Lactating or pregnant women
Pregnant or lactating females
Lactating or pregnant women
Not pregnant or lactating
Pregnant or lactating females
Lactating woman
Pregnant or lactating
EXCLUSION - TREATMENT: Pregnant or lactating
Pregnant and/or lactating women
Female patients who are lactating or pregnant
Women who are pregnant or lactating
Pregnant, likely to become pregnant, or lactating women
EXCLUSION - INFUSION: Pregnant or lactating
Lactating or pregnant
Lactating and pregnant women
TREATMENT EXCLUSION: Pregnant or lactating
Lactating or pregnant
Lactating females and/or pregnant females
Patients who are pregnant or lactating
Patient is pregnant or lactating
Pregnant women and lactating women
The patient is pregnant or lactating.
Pregnant or lactating females.
Pregnant or lactating women
Pregnant and/or lactating women
Women that are pregnant or lactating are excluded from this study
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Pregnant or lactating.
Pregnant females; (lactating females must agree not to breast feed while taking ibrutinib)
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating patients
Pregnant or lactating
Pregnant or lactating
Women who are pregnant or lactating
EXCLUSION - TREATMENT: Pregnant or lactating
Pregnant or lactating females
If they are pregnant or lactating
Is a pregnant or lactating female
Pregnant or lactating females; women of childbearing age will agree to use contraception during the protocol
Women who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating, or intending to become pregnant during the study
Pregnant or lactating, or intending to become pregnant during the study
Patients must not be pregnant or lactating
Female subject who is lactating/breastfeeding.
Is lactating or pregnant as confirmed by pregnancy tests performed within 7 days before enrollment
Patients who are pregnant or lactating, plan to get pregnant, or have a positive serum pregnancy test prior to randomization.
Non-pregnant and non-lactating
Women who are pregnant or lactating.
Women who are pregnant or lactating
Pregnant or lactating, or intending to become pregnant during or within 5 months after the last dose of study treatment Exclusion Criteria Related to Atezolizumab:
Pregnant or lactating women
Patient is pregnant or lactating and does not agree to stop breastfeeding.
Pregnant and/or lactating women
Pregnant, lactating, or not using adequate contraception.
Pregnant or lactating female.
Pregnant or lactating females
Pregnancy, lactating or breastfeeding women
Pregnant or lactating females
Patients who are pregnant or lactating.
Pregnant and/or lactating women
Pregnant or lactating females
Women who are pregnant or lactating
Pregnant or lactating females
Pregnant or lactating women
Pregnant women or lactating women who are breastfeeding are excluded from this study
Patients who are pregnant, lactating, or breastfeeding
Pregnant and lactating women
Subjects who are pregnant or are lactating
Pregnant and lactating women are excluded
Currently pregnant, lactating or breastfeeding.
Lactating women are excluding from the study
Females who are pregnant or lactating
Pregnant and lactating women are excluded from this study.
Women who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating women
Pregnancy and/or lactating.
Female subjects who are pregnant or lactating, including females with a positive pregnancy test at screening.
Patients who are pregnant or lactating
Pregnant or lactating female
Pregnant or lactating
Pregnant or lactating patients
Lactating or pregnant
Pregnant or lactating patients
Pregnant or lactating women
Pregnant or lactating female
Women who are pregnant, lactating or expecting to conceive
Is pregnant or lactating
Women who are pregnant or lactating.
If female, the patient is pregnant or lactating.
Pregnant or lactating women
Female only: pregnant or lactating
Women who are pregnant or lactating
DONOR: Pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Pregnant or lactating women
Pregnant or lactating females
Lactating or pregnant
Lactating female
Pregnant or lactating
Pregnant or lactating females
Pregnant or lactating individuals.
Lactating or pregnant
Pregnant or lactating women
Patients may not be pregnant or lactating at study registration
Females who are pregnant, lactating, or intend to become pregnant during their participation in the study
Pregnant or lactating subjects
Pregnant and/or lactating women
Be pregnant or lactating
PART 1 EXCLUSION CRITERIA: Pregnant or lactating females
PART 2 GROUP 1 EXCLUSION CRITERIA: Pregnant or lactating females
PART 2 GROUP 2A EXCLUSION CRITERIA: Pregnant or lactating females
PART 2 GROUP 3 EXCLUSION CRITERIA: Pregnant or lactating females
Pregnant or lactating women are excluded from the study
Pregnant or lactating women are excluded from this study
Female patients who are pregnant or lactating
PRIOR TO CELL PROCUREMENT: Pregnant or lactating
PRIOR TO LYMPHODEPLETION: Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating individuals.
Females who are pregnant, lactating, or intend to become pregnant during the participation of the study
Pregnant or lactating females
Pregnant or lactating female
Women that are pregnant or lactating
Pregnant or lactating women
Women who are pregnant or lactating;
Subjects must not be pregnant or lactating
Pregnant or lactating
Pregnant or lactating
Subject that is pregnancy or lactating
Females who are pregnant or lactating
Patients who are pregnant or lactating.
Females who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females
Pregnant or lactating females
Patients must not be pregnant of lactating
Lactating females
Female subject who is lactating or pregnant
Pregnant or lactating women
Pregnant or lactating woman
Pregnant or lactating women
AT THE TIME OF INFUSION: Pregnant or lactating
Pregnant or lactating
DONOR: Females must not be pregnant or lactating
Female subject is pregnant or lactating
Pregnant and lactating women
Patients who are pregnant or lactating
Lactating females
Females who are pregnant or lactating
Patients who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Lactating females
Pregnant or lactating female
Patients who are pregnant or lactating
Pregnant or lactating patients
Pregnant or lactating women
Pregnant women and women who are lactating
Pregnant or lactating individuals.
Lactating females
Female patients who are pregnant or lactating
Pregnant and lactating women are excluded from this study
Pregnant and lactating women
Patients who are pregnant or lactating
Pregnant and lactating women
Pregnant or lactating patients
Pregnant or lactating female.
Pregnant or lactating patients
Patients who are pregnant or lactating.
Patients in pregnant or lactating
Pregnant or lactating females
No pregnant or lactating females
Pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating
Patients who are pregnant or lactating are NOT eligible for participation
Patients must not be pregnant or lactating females.
Lactating females
Patient is pregnant, lactating, or planning on being pregnant within the next 6 months
RECIPIENT: Pregnant or lactating
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating females
Patients who are pregnant and/or lactating
Pregnant or lactating females
Pregnant or lactating.
Lactating females
Pregnant or lactating females
Pregnant or lactating female
Pregnant or lactating female
COHORTS 1 AND 2: HEALTHY VOLUNTEERS: Pregnant or lactating
Pregnant or lactating women
Lactating or pregnant females
Pregnant or lactating women are excluded from this study
Pregnant or lactating women.
Pregnant or lactating women
Patients who are pregnant or lactating
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant females; (lactating females must agree not to breast feed while taking the study medications)
Lactating women are excluded from study participation.
Lactating or pregnant
Pregnant or lactating women
Pregnant or lactating
Pregnant or lactating; women should not breast feed during the interval from study entry to one\r\nyear post-transplant
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females
Women who are pregnant or lactating due to potential exposure of the fetus to RT and unknown effects of RT to lactating females
Pregnant or lactating
DONOR: Pregnant or lactating women are not eligible
Pregnant and lactating females will be excluded
Pregnant or lactating female
Patients who are pregnant or lactating
Pregnant or lactating female
Female patients who are pregnant or lactating are not eligible to receive treatment but can be followed for natural history
Pregnant or lactating females
Lactating females
Patients who are pregnant or lactating;
Females who are pregnant, lactating, or breastfeeding, or who plan to become pregnant during the study
Female subject who is pregnant or lactating.
Pregnant and lactating women
Females who are pregnant or lactating or plan to become pregnant during the course of this study.
pregnant or lactating
Pregnant or Lactating.
Pregnant and/or lactating women are excluded
Patients who are pregnant or lactating
Is a pregnant or lactating female.
Patients who are pregnant and/or lactating are NOT eligible for participation
Women who are pregnant or lactating.
Women who are pregnant or lactating are NOT eligible
Pregnant or lactating
Pregnant, lactating, or not using adequate contraception
Pregnant or lactating or planning pregnancy during treatment period.
Pregnant or lactating women.
Pregnant, lactating or not using adequate contraception.
Pregnant or lactating females
Lactating or pregnant
Pregnant or lactating female.
Is pregnant or lactating.
Pregnant or lactating patients
Subjects who are pregnant or lactating;
Non-pregnant and non-lactating.
If they are pregnant or lactating
Women who are pregnant or lactating or intending to become pregnant before, during, or within 3 months after the last dose of study drug.
Lactating females.
Pregnant or lactating female.
Pregnant or lactating females
Lactating females
Who are pregnant and/or lactating
Pregnant or lactating women
Women who are pregnant or lactating.
Pregnant or lactating patients
Pregnant or lactating females
Lactating females
Pregnant or lactating patients
Lactating women
Pregnant or lactating
Pregnant or lactating females
Pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Subject is pregnant or is lactating
Subject is pregnant or lactating
Pregnant or lactating, or intending to become pregnant during the study
Lactating or pregnant females
Lactating females are not eligible
The recipient is pregnant or a lactating female
DONOR: Pregnant or lactating females
Pregnant or lactating women are ineligible
Pregnant or lactating females who chose to breast feed
Pregnant or lactating patients
Pregnant or lactating women
Pregnant or lactating women
Patients who are pregnant or lactating
Subject is pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating females
Pregnant or lactating women
Lactating or pregnant females
Patients who are pregnant or lactating
Women who are currently lactating
Women who are pregnant or lactating
Pregnant and lactating women are excluded from this study
Lactating females
Lactating or pregnant female.
Pregnant or lactating women
Lactating or pregnant females
Pregnant or lactating women
Pregnant or lactating women
Pregnant and/or lactating women are not eligible to participate in this study
Pregnant or lactating
Pregnant or lactating
Women who are pregnant or lactating or refuse to commit to use contraception anytime during the study
Participant is pregnant or lactating.
Pregnant or lactating women
Subject has had prior treatment with lenalidomide. 7. Subject is pregnant or lactating.
Pregnant or lactating female patients.
Patients who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females.
The participant is pregnant prior to randomization or lactating.
Subject is pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Women who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating women
Is a pregnant or lactating female.
Pregnant or lactating women
Female subject who is pregnant or lactating
Women who are pregnant or lactating.
Pregnant and lactating women
Pregnant or lactating
Females who are pregnant or lactating.
Matched Related Donor: Pregnant or lactating females
Unrelated Donor: Pregnant or lactating females
Pregnant or lactating women
Pregnant or lactating or intending to become pregnant during the study
Women who are pregnant or lactating
Pregnant or lactating (breastfeeding) females.
Male or non-pregnant, non-lactating female
Pregnant or lactating female
Women who are pregnant or lactating.
Pregnant or lactating women
Female patients who are pregnant or lactating.
Participants who are pregnant or lactating
DONOR: Pregnant or lactating females
Lactating or pregnant subjects
Pregnant or lactating women
Pregnant or lactating females
Lactating or pregnant
Pregnant or lactating.
Women who are pregnant or lactating or intending to become pregnant during the study
Lactating or pregnant
Pregnant or lactating women
Not pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females
Pregnant or lactating women
Male or non-pregnant and non-lactating female
Are pregnant or lactating.
Pregnant or lactating women
Pregnant or lactating women
Women who are pregnant or lactating
Pregnant or lactating women
Lactating female.
Pregnant or lactating females
Women who are pregnant or lactating Dose-Escalation Portion of the Study:
Is a pregnant or lactating female
Pregnant or lactating females.
Women who are pregnant or lactating
Pregnant or lactating women
Women who are pregnant or lactating
Pregnant or lactating women.
Pregnant or lactating women
Pregnant or lactating
Participant is pregnant or lactating
Lactating females
Pregnant or lactating women
Female: pregnant or lactating
Pregnant, likely to become pregnant, or lactating women (where pregnancy is defined as the state of a female after conception and until the termination of gestation)
Pregnant or lactating women
Pregnant or lactating women are excluded from this study
No pregnant or lactating women
Participants who are pregnant or lactating
Women who are lactating or breastfeeding
Female patients who are lactating, breastfeeding, or pregnant
Women who are pregnant or lactating
Women who are pregnant or lactating.
Women who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating females
Women who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating
Women who are pregnant or lactating are not eligible for study treatment
Lactating or pregnant women
Females who are pregnant or lactating
Lactating or pregnant subjects
Pregnant or lactating females
Pregnant or lactating female
Pregnant or lactating females
Lactating or pregnant women
Pregnant or lactating females
Pregnant and lactating women
Pregnant or lactating women
Women who are pregnant or are lactating
Pregnant or lactating females
Pregnant or lactating females
Lactating female
Women who are pregnant or lactating
Patients who are pregnant or lactating
Patients who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating females
Patients who are pregnant or lactating
Pregnant and lactating women
Currently pregnant or lactating
Subjects who are pregnant or lactating or who are planning to become pregnant during the course of the study are excluded.
Pregnant or lactating females
Pregnant or lactating women
AT THE TIME OF INFUSION: Pregnant or lactating
Pregnant or lactating women are excluded from this study
Pregnant or lactating women
Lactating or pregnant.
No pregnant or lactating females
Pregnant or lactating females
Pregnant and lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant, lactating or actively breastfeeding female subjects
Pregnant or lactating women.
Pregnant or lactating females.
Pregnant or lactating females
Pregnant or lactating females
Female patients who are pregnant or lactating
Subjects who are pregnant or lactating.
Women who are pregnant or lactating
Pregnant or lactating women
Pregnancy and/or lactating
Pregnant or lactating women
Female patients who are lactating or pregnant
Lactating females
Pregnant or lactating females
Pregnant or lactating patients
Lactating females
Pregnant or lactating females
Patient is pregnant, lactating, or breastfeeding
Pregnant or lactating women
Pregnant or lactating women
The patient, if female, is pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant and lactating women are excluded from the study
Pregnant or lactating women
Women who are pregnant or lactating are not eligible for study treatment
Pregnant or lactating females
Pregnant or lactating female
Women who are lactating;
A pregnant or lactating woman.
Pregnant or lactating patients
Women who are pregnant or lactating
Pregnant women and lactating women
Pregnant or lactating women
Pregnant or lactating patients
Pregnant or lactating women
Pregnant or lactating.
If female, is lactating.
Pregnant or lactating women
Pregnant or lactating female
Patient is pregnant or lactating
Pregnant or breastfeeding women; (lactating women must agree not to breast feed while taking 5-azacitidine)
Lactating female or female who becomes pregnant prior to transition to this study.
Pregnant or lactating females
DONOR: Female donors must not be pregnant or lactating
If female, neither pregnant nor lactating.
Pregnant or lactating women
Pregnant or lactating women
Female patients who are pregnant or lactating
Male or non-pregnant, non-lactating female patients
Pregnant or lactating
Women who are pregnant or lactating
Females who are pregnant or lactating
DONOR: Pregnant or lactating females
Lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant and lactating women
Pregnant or lactating female.
Patients cannot be lactating
Pregnant or lactating women
Pregnant or lactating women
Females who are pregnant or lactating
Pregnant or lactating female
Pregnancy or lactating females
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
EXPANSION COHORT ONLY: Female subjects who are pregnant or lactating are not eligible to participate in this study
Patients who are pregnant or lactating
Pregnant or lactating females.
Females who are pregnant or lactating.
Pregnant or lactating women
Lactating or pregnant
Pregnant or lactating females
Pregnant or lactating female;
Pregnant or lactating women
Pregnant or lactating women
Women who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females.
Pregnant or lactating women
Pregnant or lactating
Pregnant or lactating females.
Pregnant or lactating patients
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Lactating female
Female subject is pregnant or lactating
If female, participant is pregnant or lactating at the time of enrollment, or has plans to become pregnant during the study
Women who are pregnant or lactating
Women who are lactating
Patients who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating women
Lactating or pregnant.
Patients who are pregnant or lactating
Pregnant and lactating women are excluded from the study
Pregnant or lactating
Is a pregnant or lactating female.
Women who are pregnant or lactating
Lactating females
Pregnant or lactating female
Pregnant or lactating female.
Pregnant or lactating pts
DONOR: not pregnant or lactating
Pregnant or lactating
Pregnant or lactating female.
Patients who are pregnant or lactating
Pregnant or lactating female
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating
Pregnant or lactating females
Pregnant or lactating females
Pregnant and/or lactating women will be excluded
Patients who are pregnant or lactating or not practicing adequate contraception
Pregnant or lactating women
DONOR: Not pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating females
Women who are pregnant or lactating
Pregnant or lactating women
Patients who are pregnant or lactating are not eligible
Male or non-pregnant, non-lactating, females
Pregnant or lactating women
Patient is a female who is pregnant, lactating, or is planning a pregnancy during study participation, or in the follow-up period.
Pregnant or lactating women
Female subjects who are pregnant or lactating at Screening, or plan to become pregnant while on study or within 6 months after the last dose of study drug
Pregnant or lactating women
Pregnant or lactating subjects.
Pregnant or lactating female.
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating females
Woman who is pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating females
Patients who are pregnant or lactating
Participant is pregnant or lactating
Pregnant (positive pregnancy test) or lactating
Suspected pregnancy, pregnant or lactating females
Women who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Females who are pregnant or lactating
Women who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating females
Pregnant, lactating or breastfeeding females
Lactating females or pregnant females
Is a pregnant or lactating female
Pregnant or lactating women
Pregnant or lactating females
Female patients who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating female
Women who are pregnant or lactating
Female patients who are lactating or pregnant
Subject is pregnant or lactating.
Female patients who are pregnant or lactating and breastfeeding
Pregnant or lactating females
Pregnant or lactating females
Lactating female
Pregnant, lactating or planning to become pregnant
Women who are pregnant (confirmed by positive pregnancy test) or lactating
Pregnant or lactating females
Female subjects who are pregnant or lactating
Lactating or pregnant female.
Pregnant or lactating women
Pregnant or lactating women
Female patients who are pregnant or lactating.
Pregnant or lactating females
Pregnant or lactating women
Pregnant or lactating women
Patients who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating women
Pregnant or lactating women
Subject is a lactating or pregnant female.
Female patients who are lactating or pregnant
If female, pregnant or lactating
Pregnant or lactating women
Lactating women
Are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating women
Women who are lactating/breastfeeding or planning to become pregnant during the duration of the study
Pregnant or lactating females
Patient is pregnant or lactating
The participant is pregnant or lactating.
Lactating women.
Pregnant or lactating
Pregnant or lactating female
Pregnant or lactating females
Pregnant or lactating female.
For female patients: the patient is pregnant or lactating.
Currently lactating.
Women who are pregnant or lactating (cohort 1)
Women who are pregnant or lactating (Cohort 1)
Women who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating
Pregnant and lactating women are excluded from this study
Women who are pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating females.
Is a pregnant or lactating female.
The participant is pregnant or lactating
Pregnant or lactating women
Any patients with allergy to the drug; and any pregnant female or lactating.
For female patients: the patient is pregnant or lactating.
Pregnant or lactating females.
Pregnant or lactating women
Patients who are pregnant or lactating
Pregnant or lactating women
Pregnant and lactating women
Pregnant and/or lactating women will be excluded
Patients who are pregnant or lactating
Pregnant or lactating females
Pregnant or lactating women or woman of childbearing potential
Pregnant or lactating women
Self-report of being pregnant or lactating
Pregnant or lactating women
Subject is pregnant or lactating
Patients who are pregnant or lactating
Females who are pregnant or lactating
Pregnant or lactating women
Pregnant or lactating females are excluded from enrollment on this trial
Pregnant or lactating women
Pregnant or lactating
Pregnant, wanting to become pregnant or lactating women
Pregnant or lactating women; childbearing age women are not on birth control
Females who are pregnant or lactating
Pregnant or lactating women; childbearing age women are not on birth control
Lactating women
Women who are pregnant or lactating
Lactating or pregnant women
Female subjects of childbearing potential must not be pregnant or lactating at screening
Pregnant or lactating women
Lactating or pregnant
Lactating or pregnant
Patients who are pregnant or lactating
Women who are pregnant and/or lactating.
Female subjects that are pregnant or lactating.
Pregnant or lactating
Pregnant or lactating women
Treatment with systemic immunosuppressive medications - Pregnant or lactating women
Pregnant women/lactating mothers
Pregnant or lactating women (to be obtained via subject report only)
The patient is pregnant or lactating
Female patients who are pregnant or lactating at the baseline/screening visit
The subject is known or suspected to be pregnant or lactating
Women who are pregnant or lactating
Pregnant or lactating
No patients known to be pregnant or lactating
Women of childbearing potential must not be known to be pregnant or lactating
Pregnant and/or lactating within 1 year prior to screening breast MRI
Patients pregnant or lactating
Must be non-pregnant and non-lactating for at least one year prior to pre-registration
Patient is pregnant or lactating and does not agree to stop breastfeeding.
Pregnant or lactating women
Lactating female patient.
Female patients who are lactating or pregnant
Pregnant or lactating females
Pregnant or lactating
Are planning to conceive or are currently pregnant or lactating
Lactating
Pregnant or lactating females
Pregnant or lactating women
Subjects who are pregnant and/or lactating are not eligible
Pregnant or lactating women
Pregnant or lactating female.
Pregnant or lactating female patients
Pregnant or lactating women
Women who are pregnant, planning pregnancy within the next year, or lactating/breastfeeding
Female patients who are lactating or pregnant
Female patients who are lactating or pregnant
Pregnant or lactating women
Not pregnant or lactating and does not intend to become pregnant during the study
Pregnant or lactating
Pregnant or lactating female.
Women who are pregnant or lactating are excluded from the study
Patients who are pregnant or lactating
The patient is pregnant or lactating
Subjects who are pregnant or lactating or who suspect they might be pregnant
Pregnant or lactating females
Subjects who are pregnant or lactating or who suspect they might be pregnant
Subjects who are pregnant or lactating or who suspect they might be pregnant
Patients who are or might be pregnant or lactating
Women who are pregnant, possibly pregnant, or lactating
Patient who is pregnant and/or lactating
Pregnant or lactating women
Subject is pregnant or lactating
Non-pregnant and non-lactating
Female participants of childbearing age must not be lactating
Pregnant or lactating women are excluded from this study
Not pregnant or not lactating
Pregnant or lactating patients
Pregnancy or lactating female
Pregnant or lactating women
Lactating women
Pregnant or lactating female, a serum pregnancy test will be performed within 2 weeks or less before the date of the FCH PET/CT scan in all women capable of becoming pregnant
Pregnant or lactating patients
Patient is lactating (breastfeeding) or pregnant
Participants who are pregnant, lactating, or who suspect they might be pregnant are not eligible
Pregnant or lactating females
Patients who are pregnant or lactating
Pregnant or lactating
Women of childbearing potential must not be pregnant or lactating
Subjects who are pregnant or lactating
Pregnant or lactating female
Females who are pregnant or lactating or who intend to become pregnant during participation in the study are not eligible to participate.
Pregnant or lactating women
Female subjects who are pregnant or lactating
Subjects who are pregnant or lactating or who suspect they might be pregnant
Pregnant or lactating women
The subject is pregnant or lactating.
Subject is pregnant or lactating
Females who are pregnant and/or lactating
Pregnant or lactating women
Patients who are pregnant or lactating
Are women who are pregnant or lactating.
Pregnant or lactating female
women pregnant or lactating
The patient is pregnant or lactating.
Females who are lactating or pregnant.
Female who is lactating/breastfeeding.
Pregnant women or lactating women
Pregnant or lactating, or intending to become pregnant during the study
Pregnant or lactating females
